ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
6
views
0
references
Top references
cited by
12
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
197
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Pharmacoepidemiology
edited_book
Editor(s):
Brian L. Strom
,
Stephen E. Kimmel
,
Sean Hennessy
Publication date
(Online):
January 03 2012
Publisher:
Wiley-Blackwell
Read this book at
Publisher
Buy book
Review
Review book
Invite someone to review
Bookmark
Cite as...
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
ScienceOpen Research
Author and book information
Book
ISBN:
9781119959946
Publication date (Print):
February 17 2012
Publication date (Online):
January 03 2012
DOI:
10.1002/9781119959946
SO-VID:
e5175211-61d5-4564-889c-072cb9cb5214
History
Data availability:
Comments
Comment on this book
Sign in to comment
Book chapters
pp. i
Front Matter
pp. 1
What is Pharmacoepidemiology?
pp. 23
Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiologic Studies
pp. 38
Basic Principles of Clinical Epidemiology Relevant to Pharmacoepidemiologic Studies
pp. 52
Sample Size Considerations for Pharmacoepidemiologic Studies
pp. 62
When Should One Perform Pharmacoepidemiologic Studies?
pp. 71
The Role of Pharmacoepidemiology in the Health-Care System and Academia
pp. 84
The Role of Pharmacoepidemiology in Industry
pp. 107
The Role of Pharmacoepidemiology in Regulatory Agencies
pp. 117
Pharmacoepidemiology and the Law
pp. 135
Postmarketing Spontaneous Pharmacovigilance Reporting Systems
pp. 158
Overview of Automated Databases in Pharmacoepidemiology
pp. 163
Health Maintenance Organizations/Health Plans
pp. 189
Commercial Insurance Databases
pp. 209
US Government Claims Databases
pp. 224
Medical Record Databases
pp. 244
In-Hospital Databases
pp. 259
Canadian Provincial Databases
pp. 270
Pharmacy-Based Medical Record Linkage Systems
pp. 287
Case-Control Surveillance
pp. 301
Prescription-Event Monitoring
pp. 331
Registries
pp. 347
Field Studies
pp. 364
How Should One Perform Pharmacoepidemiologic Studies? Choosing among the Available Alternatives
pp. 377
Studies of Drug Utilization
pp. 402
Evaluating and Improving Physician Prescribing
pp. 423
Pharmacoepidemiologic Studies of Vaccine Safety
pp. 469
Epidemiologic Studies of Medical Devices: Methodologic Considerations for Implantable Devices
pp. 487
Studies of Drug-Induced Birth Defects
pp. 505
Risk Management
pp. 534
FDA's Sentinel Initiative: Active Surveillance to Identify Safety Signals
pp. 555
Pharmacoepidemiology and Pharmaceutical Reimbursement Policy
pp. 561
Comparative Effectiveness Research
pp. 581
Assessing Causality of Case Reports of Suspected Adverse Events
pp. 601
Molecular Pharmacoepidemiology
pp. 623
Bioethical Issues in Pharmacoepidemiologic Research
pp. 640
The Use of Randomized Controlled Trials for Pharmacoepidemiologic Studies
pp. 655
The Use of Pharmacoepidemiology to Study Beneficial Drug Effects
pp. 678
Pharmacoeconomics: Economic Evaluation of Pharmaceuticals
pp. 709
Using Quality-of-Life Measurements in Pharmacoepidemiologic Research
pp. 723
The Use of Meta-analysis in Pharmacoepidemiology
pp. 757
Validity of Pharmacoepidemiologic Drug and Diagnosis Data
pp. 795
Studies of Medication Adherence
pp. 810
Risk Evaluation and Communication
pp. 827
Studying Effects of Antibiotics
pp. 840
The Pharmacoepidemiology of Medication Errors
pp. 852
Sequential Statistical Methods for Prospective Postmarketing Safety Surveillance
pp. 868
Advanced Approaches to Controlling Confounding in Pharmacoepidemiologic Studies
pp. 893
The Future of Pharmacoepidemiology
pp. 904
Appendix A: Sample Size Tables
pp. 921
Appendix B: Glossary
pp. 931
Index
Similar content
197
Special Issue: Abstracts of the 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, September 16-17, 2020.
Authors:
Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database.
Authors:
Christina Lindemann
,
U. Schmid
,
Edeltraut Garbe
…
Pharmacoepidemiology Studies: what Levels of Evidence and how can They be Reached?
Authors:
Maryse Lapeyre-Mestre
,
Claudine Sapede
,
Nicholas Moore
…
See all similar
Cited by
11
How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias
Authors:
Robert Platt
,
Richard Platt
,
Jeffrey S. Brown
…
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database
Authors:
Maria Antonietta Barbieri
,
Paola Maria Cutroneo
,
Chiara Baratelli
…
Quantitative Signal Detection and Analysis in Pharmacovigilance
Authors:
Andrew Bate
,
Antoine Pariente
,
Manfred Hauben
…
See all cited by